Nivolumab in Primary CNS Lymphoma and Primary Testicular Lymphoma with CNS Involvement: Single Center Experience by Gavrilenko, Andrey N., Volkov, Nikita P., Shmidt, Daniil I., Polushin, Alexey Y., Kondakova, Elena, Lepik, Kirill V., Zalaylov, Yuri R., Popova, Marina O., Kulagin, Aleksandr D., Afanasyev, Boris V., Mikhailova, Natalia B.

Get full text

CAR T Cells in T Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma by Shmidt, Daniil, Mamonkin, Maksim

Get full text

SOHO State of the Art Updates and Next Questions | CAR T Cells in T Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma by Shmidt, Daniil, Mamonkin, Maksim

Get full text

EXABS-135-ALL Development of CAR T-Cells for T-ALL and LBL by Shmidt, Daniil, Mamonkin, Maksim

Get full text

PB2308: NIVOLUMAB‐BASED THERAPY OF RELAPSED OR REFRACTORY PRIMARY LARGE B‐CELL LYMPHOMA OF IMMUNE‐PRIVILEGED SITES AND DLBCL WITH SECONDARY CNS INVOLVEMENT by Gavrilenko, Andrey, Markelov, Vladislav, Volkov, Nikita, Shmidt, Daniil, Skiba, Yaroslav, Kondakova, Elena, Kirill, Lepik, Fedorova, Liudmila, Popova, Marina, Mikhaylova, Natalya, Kulagin, Alexander

Get full text

Chimeric antigen receptor-induced antigen loss protects CD5.CART cells from fratricide without compromising on-target cytotoxicity by Ma, Royce, Woods, Mae, Burkhardt, Phillip, Crooks, Noah, van Leeuwen, Dayenne G., Shmidt, Daniil, Couturier, Jacob, Chaumette, Alexandre, Popat, Divya, Hill, LaQuisa C., Rouce, Rayne H., Thakkar, Sachin, Orozco, Aaron F., Carisey, Alexandre F., Brenner, Malcolm K., Mamonkin, Maksim

Get full text